RNS Announcement
11 March 2024
AIM: SYN
Financing Update
Synergia Energy Ltd (AIM: SYN) (the "Company") provides an update in relation to the 9 March 2024 maturity date of the 6,500 convertible loan notes issued by the Company effective 9 March 2023.
The Company will this week repay in cash the sum of
The Company will issue 140,455,821 new ordinary shares of the Company in relation to conversion of the balance of the convertible loan notes. An application for the admission to trading on AIM of these new ordinary shares is expected to be made in early April.
Per the Company's announcement of 14 February 2024, the Company has signed a farm-out agreement with Selan Exploration Technology Limited (Selan) to transfer 50% of the Cambay PSC to Selan and awaits Government of
In order to minimise equity dilution for shareholders, the Company has obtained loan funding from existing investors of
Further, the Company has noted recent market speculation / rumours suggesting that the Company was completing an equity financing and can confirm the Company has no plans to finance the Company by way of equity at this current time.
For and on behalf of Synergia Energy Ltd
Roland Wessel
CEO
For further information, please contact:
Investor Enquires Synergia Energy Ltd Briana Stayt Investor Relations Email: bstayt@synergiaenergy.com Tel: +61 8 9485 3200 |
AIM Joint Broker Panmure Gordon ( Broker Mark Murphy / Hugh Rich / Freddie Wooding Tel: +44 (0)20 7886 2500 |
AIM Joint Broker Novum Securities Broker Colin Rowbury Email: crowbury@novumsecurities.com Tel: +44 20 7399 9427 |
AIM Nominated Adviser Strand Hanson Limited Nominated Adviser Ritchie Balmer / Rory Murphy Tel: +44 20 7409 3494 |
Media Enquires ( Vigo Consulting Investor Relations Patrick d'Ancona / Finlay Thomson Email: patrick.dancona@vigoconsulting.com finlay.thomson@vigoconsulting.com Tel:+ 44 20 7390 0230 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.